Recruiting Geographic Atrophy Studies in Indianapolis
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
The purpose of this study is to find out whether a medicine called spesolimab helps people with pyoderma gangrenosum (PG). The main aim is to see whether spesolimab leads to closure of PG ulcers. This...
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovi...
About Geographic Atrophy Clinical Trials in Indianapolis
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 2 geographic atrophy clinical trials recruiting participants in Indianapolis, INDIANA. These studies are seeking a combined 110 participants. Research is being sponsored by Boehringer Ingelheim, New York Medical College. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Indianapolis — FAQ
Are there geographic atrophy clinical trials in Indianapolis?
Yes, there are 2 geographic atrophy clinical trials currently recruiting in Indianapolis, INDIANA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Indianapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.
Are clinical trials in Indianapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 2 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated March 2, 2026 from ClinicalTrials.gov